The world's largest measles-Rubella vaccination campaign in Pakistan : Time to invest in routine immunization
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Human vaccines & immunotherapeutics - 18(2022), 5 vom: 30. Nov., Seite 2080444 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rana, Muhammad Suleman [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.11.2022 Date Revised 02.11.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/21645515.2022.2080444 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343229862 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343229862 | ||
| 003 | DE-627 | ||
| 005 | 20231226204942.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/21645515.2022.2080444 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1144.xml |
| 035 | |a (DE-627)NLM343229862 | ||
| 035 | |a (NLM)35802459 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rana, Muhammad Suleman |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The world's largest measles-Rubella vaccination campaign in Pakistan |b Time to invest in routine immunization |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2022 | ||
| 500 | |a Date Revised 02.11.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Measles Vaccine |2 NLM | |
| 650 | 7 | |a Rubella Vaccine |2 NLM | |
| 700 | 1 | |a Usman, Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Alam, Muhammad Masroor |e verfasserin |4 aut | |
| 700 | 1 | |a Ikram, Aamer |e verfasserin |4 aut | |
| 700 | 1 | |a Salman, Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Umair, Massab |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human vaccines & immunotherapeutics |d 2012 |g 18(2022), 5 vom: 30. Nov., Seite 2080444 |w (DE-627)NLM21576823X |x 2164-554X |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2022 |g number:5 |g day:30 |g month:11 |g pages:2080444 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/21645515.2022.2080444 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2022 |e 5 |b 30 |c 11 |h 2080444 | ||